Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signallingXin Zhuo, Yuhong Jiang|Acta Pharmaceutica Sinica B|2023Cited by 11